Dr. Yongjun WANG As The First Asian Winner of William M. Feinberg Award, Pioneering Stroke Research at ISC 2025

Great news for Chinese clinical scientists in stroke care! Recently, Dr. Yongjun WANG, a distinguished clinical scientist and leader in stroke research from China, has been honored with the prestigious William M. Feinberg Award for Excellence in Clinical Stroke at the 2025 International Stroke Conference (ISC). This award is the first ever presented to an Asian scientist, marking a significant milestone in the recognition of Dr. Wang’s contributions to the field.

The William M. Feinberg Award is named after Professor William M. Feinberg, a renowned stroke clinician and researcher whose work has significantly advanced our understanding of stroke causes and treatments. The award is bestowed upon individuals who have demonstrated exceptional achievement in clinical stroke research and practice, highlighting their impact on improving patient outcomes.

Dr. Wang, President of Beijing Tiantan Hospital, Capital Medical University and President of the Chinese Stroke Association, has been leading groundbreaking research that has profoundly influenced global stroke care. Over the past three decades, there have been 12 pivotal studies that have shaped clinical guidelines and practices in stroke referfusion worldwide. Dr. Wang and his team has contributed 5 of them.

Currently, Dr. Wang is spearheading several ongoing clinical trials, including those exploring the use of Tenecteplase for managing minor ischemic strokes, interventions for basilar artery occlusion, and treatments for ischemic stroke occurring at very late time windows. His work has not only influenced acute care practices but also contributed to stroke prevention strategies.

The impact of Dr. Wang’s research extends beyond China; his findings have worldwide significance, particularly in the realm of intravenous reperfusion therapy. Many clinicians worldwide have cited his studies as foundational to their practice, underscoring the profound influence of his work on global stroke care.

Dr. Bijou Menon, professor of neurology at the University of Calgary and ISC vice-chair, emphasized that Dr. Wang’s achievements are not limited to a single area but encompass various domains, including acute stroke management, reperfusion therapy, imaging, and stroke prevention.

This award underscores the significant role Dr. Wang has played in advancing stroke research and practice, serving as an inspiration for countless professionals worldwide. His contributions continue to shape the future of stroke care, and his ongoing trials promise further advancements in this critical area of medicine. Let’s look forward to more new insights and discoveries from Prof. Wang and his team!